Reproductive Endocrinologist Dr. Jamie Stanhiser Joins RMA San Diego, Strengthening Fertility Care in the Region

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

IVI RMA North America, a leader in fertility care and assisted reproduction, today announced that Dr. Jamie Stanhiser, a reproductive endocrinologist with more than a decade of experience in reproductive medicine and women’s health, has joined the RMA San Diego clinical team. Double board-certified in Obstetrics and Gynecology, and Reproductive Endocrinology and Infertility, Dr. Stanhiser also serves as a Clinical Assistant Professor at the University of California, San Diego.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706390629/en/

Dr. Jamie Stanhiser, Reproductive Endocrinologist, IVI RMA North America

Dr. Jamie Stanhiser, Reproductive Endocrinologist, IVI RMA North America

“A recognized leader in fertility care, Dr. Stanhiser has presented nationally and published extensively on natural fertility, IVF outcomes, reproductive health, and the psychosocial aspects of fertility,” said Dr. Scott Morin, West Coast Medical Director at IVI RMA North America. “We are thrilled to have her join our San Diego clinical team and improve patient outcomes through evidence-based, personalized care. As more individuals and couples proactively plan for their futures, timely access to expert fertility care is critical—and with Dr. Stanhiser now seeing patients, individuals and couples have a new opportunity to connect with a specialist as they consider their options.”

Dr. Stanhiser earned her medical degree from Loma Linda University School of Medicine and completed her OB/GYN residency at the Cleveland Clinic–where she served as Chief Administrative Resident. She went on to complete a fellowship in Reproductive Endocrinology and Infertility at the University of North Carolina at Chapel Hill. She also holds a Master of Science in Clinical Research.

“Fertility care is never one-size-fits-all, and my goal is to combine the latest evidence-based treatments with compassionate, individualized care so every patient feels supported, informed, and empowered on their journey,” said Dr. Stanhiser. “I am passionate about educating patients and improving outcomes through evidence-based, personalized care and especially committed to helping individuals and couples in San Diego navigate infertility, recurrent pregnancy loss, and fertility preservation to build or grow their families.”

Dr. Stanhiser is now accepting new patients for telehealth and in-person appointments at RMA San Diego located at 4510 Executive Drive, Suite 150. Schedule a consultation here or call 866-762-3140.

About IVI RMA North America

IVI RMA North America, comprising Reproductive Medicine Associates, Boston IVF, and Toronto-based TRIO, spans 27 IVF laboratories, resulting in the birth of over 220,000 babies to date. Pioneers in innovative care, including PGT-A, single embryo transfer, fertility preservation, LGBTQ+ care, and more, the network has published over 1,000 papers which have pushed the fertility industry forward. IVI RMA North America is part of IVI RMA Global, the world's leading Reproductive Medicine group committed to providing evidence-based fertility solutions to patients seeking treatment anywhere in the world. IVI RMA Global employs more than 5,000 people across 200+ locations in 15 countries. Learn more at rmanetwork.com and ivirma.com.

“We are thrilled to have Dr. Stanhiser join our San Diego clinical team and improve patient outcomes through evidence-based, personalized care," said Dr. Scott Morin, West Coast Medical Director at IVI RMA North America.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.16
+1.49 (0.61%)
AAPL  312.66
+4.03 (1.31%)
AMD  552.05
+34.23 (6.61%)
BAC  59.90
+1.17 (1.99%)
GOOG  364.90
+8.72 (2.45%)
META  600.29
+17.39 (2.98%)
MSFT  386.74
-3.75 (-0.96%)
NVDA  195.55
+0.72 (0.37%)
ORCL  143.76
+3.49 (2.49%)
TSLA  419.77
+26.32 (6.69%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.